The Healthcare and Private Equity teams advised Shields Health Solutions on its definitive agreement through which Welsh, Carson, Anderson & Stowe (WCAS) and Walgreen Co. will make equity investments in Shields.
Shields, the nation’s leader in patient-centric, integrated, hospital-owned specialty pharmacy care is taking on the investments as Shields continues to accelerate its national expansion. Shields currently partners with a network of more than 30 leading health systems nationwide to create on site, health system-owned specialty pharmacy programs, providing tightly integrated care management across more than 30 complex specialty disease states, including oncology, neurology, rheumatology and diabetes.
Through the agreement with WCAS, a health care and technology-focused private equity firm and Walgreens, one of the nation’s largest drugstore chains and a trusted provider of pharmacy services, Shields plans to also expand into new disease states and integrated service and technology offerings.
The Goodwin team is led by partner Stuart Cable and includes partners Robert Whalen, David Henken, Ed Amer and Roger Cohen.
For more details on the agreement, read the press release and articles in The Boston Globe and Forbes.